SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 4
|
records per page:
next > | last >>
|
|
pages:
1
2
3
4
|
presentations:
1 to
50 of
163
|
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
MDR-TB EPIDEMIOLOGY AND TRANSMISSION DYNAMICS
N. Sarita Shah
Centers for Disease Control and Prevention, Atlanta, GA, USA
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
EMERGING TREATMENT ISSUES IN MDR-TB
Francesca Conradie
University of the WItswatersrand, Johannesburg, South Africa
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
NEW DIAGNOSTIC TECHNOLOGIES FOR MDR-TB
Catharina C Boehme
Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
THE CHALLENGES OF TREATING MDR-TB IN CHILDREN
H. Simon Schaaf
Stellenbosch University, Cape Town, South Africa
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
SYMPOSIUM: STRANGERS IN THE NIGHT: CHALLENGES AND OPPORTUNITIES IN STI CONTROL
VAGINAL MICROBIOME AND SUSCEPTIBILITY TO HIV
R. Scott McClelland
University of Washington, Seattle, WA, USA
SYMPOSIUM: STRANGERS IN THE NIGHT: CHALLENGES AND OPPORTUNITIES IN STI CONTROL
ANTIBIOTIC PROPHYLAXIS FOR STIs: PROMISES OR PERILS
Jean-Michel Molina
Hôpital St Louis, Paris, France
SYMPOSIUM: STRANGERS IN THE NIGHT: CHALLENGES AND OPPORTUNITIES IN STI CONTROL
SYPHILIS IN THE ERA OF TREATMENT AS PREVENTION AND PRE-EXPOSURE PROPHYLAXIS
Matthew R Golden
University of Washington, Seattle, WA, USA
SYMPOSIUM: STRANGERS IN THE NIGHT: CHALLENGES AND OPPORTUNITIES IN STI CONTROL
SCALE-UP OF POINT-OF-CARE TESTS FOR SEXUALLY TRANSMISSIBLE INFECTIONS
Rebecca J Guy
Kirby Institute, University of New South Wales, Sydney, Australia
SYMPOSIUM: VISIONS OF HIV CURE
VISUALIZING PERSISTENT HIV IN CLINICAL SAMPLES
Daniel E Kaufmann
University of Montreal, Montreal, Canada
SYMPOSIUM: VISIONS OF HIV CURE
CHARACTERIZING HIV EXPRESSION IN VIVO
Mary F Kearney
National Cancer Institute, National Institutes of Health, Frederick, MD, USA
SYMPOSIUM: VISIONS OF HIV CURE
IMMUNE-BASED INTERVENTIONS TARGETING INFLAMMATION AND VIRAL PERSISTENCE
Mirko Paiardini
Emory University School of Medicine, Atlanta, GA, USA
SYMPOSIUM: VISIONS OF HIV CURE
THERAPEUTIC VACCINATION FOR HIV/SIV: WHAT WILL IT TAKE FOR CURE?
Louis J Picker
Oregon Health and Science University, Beaverton, OR, USA
SYMPOSIUM: CREATING AND DESTROYING HIV CAPSIDS
THE FATES AND FOLDS OF HIV-1 RNA
Alice Telesnitsky
University of Michigan, Ann Arbor, MI, USA
SYMPOSIUM: CREATING AND DESTROYING HIV CAPSIDS
STRUCTURE AND FUNCTION OF IMMATURE AND MATURE HIV CAPSIDS
Hans-Georg Kräusslich
Heidelberg University, Heidelberg, Germany
SYMPOSIUM: CREATING AND DESTROYING HIV CAPSIDS
A ROLE OF HIV-1 INTEGRASE IN ENCAPSIDATION OF THE VIRAL RNA GENOME
Mamuka Kvaratskhelia
The Ohio State University, Columbus, OH, USA
SYMPOSIUM: CREATING AND DESTROYING HIV CAPSIDS
TRIM5ALPHA RECOGNITION OF THE HIV CAPSID
Barbie K Ganser-Pornillos
University of Virginia, Charlottesville, VA, USA
SYMPOSIUM: GETTING TO THE THIRD 90
ACTING OR NOT ACTING ON VIRAL LOAD
Steven J Reynolds
NIAID, National Institutes of Health, Washington, DC, USA
SYMPOSIUM: GETTING TO THE THIRD 90
MEASURING VIRAL LOAD: INNOVATIONS AND TAKING TO SCALE
Rosanna W Peeling
London School of Hygiene and Tropical Medicine, London, United Kingdom, United Kingdom
SYMPOSIUM: GETTING TO THE THIRD 90
USING TECHNOLOGY TO IMPROVE ADHERENCE
Richard T Lester
University of British Columbia, Vancouver, BC, Canada
SYMPOSIUM: GETTING TO THE THIRD 90
REACHING KEY AND VULNERABLE POPULATIONS TO ACHIEVE THE THIRD 90
Ruanne V Barnabas
University of Washington, Seattle, WA, USA
SYMPOSIUM: HEPATITIS/LIVER
SYMPOSIUM CONVENER
Massimo Puoti
ASST GOM Niguarda, Milan, Italy
SYMPOSIUM: HEPATITIS/LIVER
HEPATITIS B: PROGRESS AND PROSPECTS IN HEPATITIS B VIRUS CURE
Patrick Kennedy
Queen Mary University London, London, United Kingdom
SYMPOSIUM: HEPATITIS/LIVER
MANAGEMENT OF CHRONIC HEPATITIS B DURING PREGNANCY
Mindie H Nguyen
Stanford University Medical Center, Palo Alto, CA, USA
SYMPOSIUM: HEPATITIS/LIVER
HEPATITIS C VIRUS: GONE BY 2030?
John W. Ward
Centers for Disease Control and Prevention, Atlanta, GA, USA
SYMPOSIUM: HEPATITIS/LIVER
FATTY LIVER DISEASE: A GROWING CONCERN
Rohit Loomba
University of California San Diego, La Jolla, CA, USA
SYMPOSIUM: THE FIRST AGE: INFANTS ON THE WORLD STAGE
MTCT: EVOLVING EPIDEMIOLOGY AND PREGNANCY OUTCOMES
Roger L Shapiro
Harvard TH Chan School of Public Health, Boston, MA, USA
SYMPOSIUM: THE FIRST AGE: INFANTS ON THE WORLD STAGE
THE ART AND SCIENCE OF INFANT DIAGNOSIS
Martina Penazzato
World Health Organization, Geneva, Switzerland
SYMPOSIUM: THE FIRST AGE: INFANTS ON THE WORLD STAGE
THE HIV-EXPOSED AND UNINFECTED CHILD: WHAT'S TO WORRY?
Claire Thorne
University College London, London, United Kingdom
SYMPOSIUM: THE FIRST AGE: INFANTS ON THE WORLD STAGE
THE TREATMENT OF NEWBORNS AND INFANTS LIVING WITH HIV
Elizabeth Maleche Obimbo
University of Nairobi, Nairobi, Kenya
SYMPOSIUM: LEVERAGING THE PLATFORM: RESPONDING TO NONCOMMUNICABLE DISEASES
SYMPOSIUM CONVENER
Peter Godfrey-Faussett
UNAIDS, Geneva, Switzerland
SYMPOSIUM: LEVERAGING THE PLATFORM: RESPONDING TO NONCOMMUNICABLE DISEASES
OVERVIEW OF THE GLOBAL BURDEN OF NONCOMMUNICABLE DISEASES IN HIV INFECTION
Pragna Patel
Centers for Disease Control and Prevention, Atlanta, GA, USA
SYMPOSIUM: LEVERAGING THE PLATFORM: RESPONDING TO NONCOMMUNICABLE DISEASES
CARDIOVASCULAR DISEASE AMONGST PEOPLE LIVING WITH HIV IN AFRICA
Gerald Yonga
Aga Khan University, Nairobi, Kenya
SYMPOSIUM: LEVERAGING THE PLATFORM: RESPONDING TO NONCOMMUNICABLE DISEASES
CAN WE LEVERAGE HIV PLATFORMS FOR PREVENTION OF CERVICAL CANCER IN LMICs IN SUB-SAHARAN AFRICA?
Doreen Ramogola-Masire
University of Botswana-University of Pennsylvania Collaboration, Gaborone, Botswana
SYMPOSIUM: LEVERAGING THE PLATFORM: RESPONDING TO NONCOMMUNICABLE DISEASES
MINIMIZING MORBIDITY: INTEGRATING CARE FOR DEPRESSION AND HIV IN LOW-RESOURCE SETTINGS
Pamela Collins
National Institute of Mental Health, Bethesda, MD, USA
SYMPOSIUM: LEVERAGING THE PLATFORM: RESPONDING TO NONCOMMUNICABLE DISEASES
HIV-1 DRUG RESISTANCE IN RESOURCE-LIMITED SETTINGS
Ravindra K Gupta
University College London, London, United Kingdom
LONG-ACTING ANTIRETROVIRAL THERAPY: A SHOT IN THE DARK OR A PARADIGM SHIFT?
Charles W Flexner
Johns Hopkins University, Baltimore, MD, USA
SIMPLE ART: MORE COMPLEX THAN THOUGHT
Jose R Arribas
Hospital La Paz, Madrid, Spain
TOWARD AN IDEAL ANTIRETROVIRAL REGIMEN FOR THE GLOBAL EPIDEMIC
Beatriz Grinsztejn
Fiocruz, Rio de Janeiro, Brasil, Brazil
SYMPOSIUM: PATHS INTERTWINED: BROADLY NEUTRALIZING ANTIBODIES AND THE HIV-1 ENVELOPE TRIMER
SYMPOSIUM CONVENER
Nicole Doria-Rose
National Institutes of Health, Bethesda, MD, USA
SYMPOSIUM: PATHS INTERTWINED: BROADLY NEUTRALIZING ANTIBODIES AND THE HIV-1 ENVELOPE TRIMER
NEUTRALIZING ANTIBODY DEVELOPMENT DURING HIV-1 INFECTION
Penny Moore
University of Witwatersrand, Johannesburg, South Africa
SYMPOSIUM: PATHS INTERTWINED: BROADLY NEUTRALIZING ANTIBODIES AND THE HIV-1 ENVELOPE TRIMER
IMMUNOGEN DESIGN TO INDUCE HIV NEUTRALIZING ANTIBODIES
William R Schief
Scripps Research Institute, La Jolla, CA, USA
SYMPOSIUM: PATHS INTERTWINED: BROADLY NEUTRALIZING ANTIBODIES AND THE HIV-1 ENVELOPE TRIMER
STRUCTURAL STUDIES OF HIV NEUTRALIZING ANTIBODIES
Andrew B Ward
Scripps Research Institute, La Jolla, CA, USA
SYMPOSIUM: PATHS INTERTWINED: BROADLY NEUTRALIZING ANTIBODIES AND THE HIV-1 ENVELOPE TRIMER
CLINICAL STUDIES WITH BROADLY NEUTRALIZING ANTIBODIES
Michel Nussenzweig
Rockefeller University, New York, NY, USA
Symposium: A Beautiful Mind: Keeping It
CNS HIV Infection: Cerebrospinal Fluid and Blood Biomarkers
Magnus Gisslén
University of Gothenburg, Gothenburg, Sweden
Symposium: A Beautiful Mind: Keeping It
Neuroimaging of HIV in the Brain
Beau M. Ances
Washington University in St. Louis, St. Louis, MO, United States
Symposium: A Beautiful Mind: Keeping It
CNS as an HIV Reservoir
Ronald I. Swanstrom
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Symposium: A Beautiful Mind: Keeping It
Therapeutics of the CNS With HIV Infection
Andrea Calcagno
University of Torino, Torino, Italy
Symposium: Global Impact of Hepatitis
Symposium Convener
Gottfried Hirnschall
World Health Organization, Geneva, Switzerland
|
<< first | < prev
page:
of 4
|
records per page:
next > | last >>
|
|
pages:
1
2
3
4
|
presentations:
1 to
50 of
163
|
